Dr Reddy's Labs will pay a final dividend of Rs 8 per share for the financial year 2025, with a total distribution of Rs 667 crore to nearly 4.6 lakh shareholders.
Today is the last day for investors to buy Dr Reddy's Laboratories Ltd. shares to qualify for the dividend before the stock goes ex/record-date.
The company will announce its June quarter results on July 23. Retail investors owning nominal share capital up to Rs 2 lakh own 8.12% equity in the company, with a payout of around Rs 54 crore for this segment.
There is focus on Dr. Reddy's Laboratories and other pharmaceutical companies like Gland Pharma Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., among others, after US President Donald Trump threatened 200% tariffs on pharmaceutical products, potentially impacting Indian drugmakers heavily due to significant sales to the US.